浮针疗法联合口服消髓化核汤治疗腰椎间盘突出症的临床研究  

A clinical study of floating acupuncture therapy combined with oral application of Xiaosui Huahe Tang(消髓化核汤)for treatment of lumbar disc herniation

作　　者：程慧[1] 郑伟[1] 张暑岚 时晓华 白玉[1] CHENG Hui;ZHENG Wei;ZHANG Shulan;SHI Xiaohua;BAI Yu(Zhengzhou Orthopedics Hospital,Zhengzhou 450052,Henan,China)

机构地区：[1]郑州市骨科医院,河南郑州450052

出　　处：《中医正骨》2024年第7期17-21,50,共6页The Journal of Traditional Chinese Orthopedics and Traumatology

摘　　要：目的:探讨浮针疗法联合口服消髓化核汤治疗腰椎间盘突出症的临床疗效。方法:将60例腰椎间盘突出症患者随机分为联合治疗组和消髓化核汤治疗组,每组30例。联合治疗组采用浮针疗法联合口服消髓化核汤治疗,消髓化核汤治疗组单纯采用口服消髓化核汤治疗。浮针疗法每隔3~4 d进行1次,共治疗5~6次,消髓化核汤连续口服20 d。比较2组患者治疗前和治疗结束后1 d的腰腿部疼痛视觉模拟量表(visual analogue scale,VAS)评分、Oswestry功能障碍指数(Oswestry disability index,ODI)及治疗结束后12个月的腰椎间盘突出重吸收率。结果:联合治疗组退出3例、消髓化核汤治疗组退出5例。治疗结束后1 d,2组患者腰腿部疼痛VAS评分、ODI均低于治疗前[(7.07±1.71)分,(2.97±1.81)分,t=27.981,P=0.000;(7.18±1.52)分,(3.99±1.87)分,t=28.198,P=0.000;(33.53±7.60)%,(9.20±6.47)%,t=29.734,P=0.000;(33.40±7.70)%,(14.00±7.62)%,t=29.541,P=0.000];治疗前,2组患者腰腿部疼痛VAS评分、ODI的组间差异无统计学意义(t=0.263,P=0.793;t=0.067,P=0.946);治疗结束后1 d,联合治疗组患者腰腿部疼痛VAS评分、ODI均低于消髓化核汤治疗组(t=2.155,P=0.035;t=2.631,P=0.011)。治疗结束后12个月,联合治疗组患者椎间盘突出重吸收率高于消髓化核汤治疗组[(36.61±15.31)%,(22.47±9.72)%,t=-4.268,P=0.000]。结论:浮针疗法联合口服消髓化核汤治疗腰椎间盘突出症,能够缓解疼痛、改善腰椎功能,促进椎间盘突出重吸收,且疗效优于单纯口服消髓化核汤。Objective:To investigate the clinical outcome of floating acupuncture therapy combined with oral application of Xiaosui Huahe Tang(消髓化核汤,XSHHT)for treatment of lumbar disc herniation(LDH).Methods:Sixty LDH patients were randomized into combined therapy group and XSHHT therapy group,30 cases in each group.The patients in combined therapy group were treated with floating acupuncture therapy and oral application of XSHHT,while the ones in XSHHT therapy group with oral application of XSHHT alone.The floating acupuncture therapy was performed once every 3-4 days for consecutive 5-6 times;the XSHHT was taken one dose a day in the morning and evening respectively for consecutive 20 days.The lumbago-leg pain visual analogue scale(VAS)score and Oswestry disability index(ODI)evaluated before the treatment and at 1 day after the end of treatment,respectively,as well as the LDH reabsorption rate evaluated at 12 months after the end of treatment were compared between the 2 groups.Results:Three patients in combined therapy group and 5 cases in XSHHT therapy group dropped out of the study.The lumbago-leg pain VAS score and ODI decreased at 1 day after the end of treatment compared to pre-treatment(7.07±1.71 vs 2.97±1.81 points,t=27.981,P=0.000;7.18±1.52 vs 3.99±1.87 points,t=28.198,P=0.000;33.53±7.60 vs 9.20±6.47%,t=29.734,P=0.000;33.40±7.70 vs 14.00±7.62%,t=29.541,P=0.000).The differences in lumbago-leg pain VAS score and ODI were not statistically significant between the 2 groups before the treatment(t=0.263,P=0.793;t=0.067,P=0.946);while,at 1 day after the end of treatment,the lumbago-leg pain VAS score and ODI were lower in combined therapy group compared to XSHHT therapy group(t=2.155,P=0.035;t=2.631,P=0.011).At 12 months after the end of treatment,the LDH reabsorption rate was higher in combined therapy group compared to XSHHT therapy group(36.61±15.31 vs 22.47±9.72%,t=-4.268,P=0.000).Conclusion:Floating acupuncture therapy combined with oral application of XSHHT can relieve the pain,improve the lumbar

关 键 词：椎间盘移位 腰椎 浮针疗法 消髓化核汤 重吸收 

分 类 号：R274.9[医药卫生—中西医结合]